Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Zomedica Pharmaceuticals Corp (NY: ZOM )

0.1202 UNCHANGED
Official Closing Price Updated: 8:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zomedica Pharmaceuticals Corp

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Zomedica(R) Supports Feline Animal Health With American Association of Feline Practitioners' Sponsorship
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence. 
From Zomedica Corp.
Via AccessWire
Stocks That Hit 52-Week Lows On Thursday
During Thursday, 849 stocks hit new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 784 companies set new 52-week lows. 
Via Benzinga
Continue to Steer Clear of MULN Stock
Small-cap, battleground EV play MULN stock could deliver a blow to bears, but for today investors should simply avoid a poor investment. 
Via InvestorPlace
Dogs Win, Investors Lose With Zomedica
Zomedica still has cash from pushing its Truforma device last year, but the future of ZOM stock is based on PulseNet, bought in October. 
Via InvestorPlace
It’s Going to Take a Lot to Get Zomedica Stock Out of the Doghouse
ZOM stockholders are likely to grow increasingly frustrated with management's misplaced optimism and the lack of Truforma sales. 
Via InvestorPlace
Zomedica to Present at H.C. Wainwright Global Investment Conference
ANN ARBOR, MI / ACCESSWIRE / April 27, 2022 / Zomedica Corp. (NYSE American:ZOM), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals,... 
From Zomedica Corp.
Via AccessWire
Zomedica's Announces Designation of Pulsevet System as the Official Shock Wave Therapy of the American Quarter Horse Association
ANN ARBOR, MI / ACCESSWIRE / April 13, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion... 
From Zomedica Corp.
Via AccessWire
Zomedica Announces Launch of eACTH Assay for Truforma(R) Platform
ANN ARBOR, MI / ACCESSWIRE / April 4, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion... 
From Zomedica Corp.
Via AccessWire
Zomedica (NYSE American: ZOM) Featured in Coverage of Investor Summit Group’s Q1 Virtual Event
Via Investor Brand Network
Zomedica’s Shareholders Should Be Worried About the Outlook of ZOM Stock
ZOM stock has been a toxic asset for nearly a year, and Zomedica isn't giving investors much to get enthused about. 
Via InvestorPlace
Zomedica (NYSE American: ZOM) Featured in Coverage of Investor Summit Group’s Q1 Virtual Event
Via CryptoCurrencyWire
Will the PulseVet Acquisition Continue to Deliver Sales for Zomedica?
ΖΟM stock is a penny stock that is trying to make a turnaround. A positive catalyst is present in the form of sales growth. 
Via InvestorPlace
Zomedica Corporation Reports 2021 Fourth Quarter & Full Year Results
ANN ARBOR, MI / ACCESSWIRE / March 1, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion... 
From Zomedica Corp.
Via AccessWire
Zomedica Announces Fourth Quarter and 2021 Revenues of $4.1 Million; 73.9% Gross Margin
ANN ARBOR, MI / ACCESSWIRE / February 25, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion... 
From Zomedica Corp.
Via AccessWire
Earnings Scheduled For February 25, 2022
Companies Reporting Before The Bell • ACM Research (NASDAQ:ACMR) is estimated to report quarterly earnings at $0.64 per share on revenue of $89.53 million. •... 
Via Benzinga
My Top Things To Expect This Week
This week will bring earnings that give insight into multiple investment themes and other important events that you should watch out for. 
Via InvestorPlace
26 Stocks Moving in Friday's Pre-Market Session
Gainers Energy Vault Holdings, Inc. (NYSE: NRGV) rose 34.2% to $14.90 in pre-market trading after jumping around 14% on Thursday. Energy Vault Holdings recently started... 
Via Benzinga
56 Biggest Movers From Yesterday
Gainers HOOKIPA Pharma Inc. (NASDAQ: HOOK) gained 54.5% to close at $2.07 on Wednesday. Hookipa Pharma amended and restated collaboration and license agreement with Gilead... 
Via Benzinga
Zomedica Appoints Adrian Lock to Lead Sales Organization
ANN ARBOR, MI / ACCESSWIRE / February 15, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion... 
From Zomedica Corp.
Via AccessWire
Zomedica Announces Management Team Additions
ANN ARBOR, MI / ACCESSWIRE / February 9, 2022 / Zomedica Corp. (NYSE:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals,... 
From Zomedica Corp.
Via AccessWire
Zomedica Provides Updates on PulseVet Sales & Marketing Integration and Marketing Activities for the First Quarter of 2022
ANN ARBOR, MI / ACCESSWIRE / January 27, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion... 
From Zomedica Corp.
Via AccessWire
Zomedica Stock Should Have Popped on This Latest Acquisition, so Beware
So when an intriguing acquisition has failed to boost ZOM stock, investors should ask why that’s the case. 
Via InvestorPlace
Zomedica CEO Provides Update to Shareholders
ANN ARBOR, MI / ACCESSWIRE / January 10, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion... 
From Zomedica Corp.
Via AccessWire
3 Most-Shorted Stocks at 52-Week Lows to Buy
In a market made up of stocks, these three most-shorted stocks look poised to deliver a much happier 2022 to bullish investors. 
Via InvestorPlace
There’s a Reason to Consider Buying Zomedica, and It’s a Real Shocker
ZOM stock is far from a market darling, but an underreported acquisition could breathe new life into Zomedia's struggling business. 
Via InvestorPlace
Zomedica Remains a Speculative Play in the Veterinary Field
The dismal run of ZOM Stock likely to continue for the foreseeable future, until it meaningfully improves its top and bottom-line numbers. 
Via InvestorPlace
Analysis: Robinhood's 2 Top Losers From Its 'Most Popular' Watchlist
Centro Electric Group Ltd. (NASDAQ:NAKD) and Zomed... 
Via Benzinga
Top 10 Meme Stocks of 2021 and How They’ll Fare in 2022
Retail investors continue to price meme stocks higher. So it's time to look at 10 meme stocks and consider how they'll fare in 2022. 
Via InvestorPlace
Zomedica to Present at H.C. Wainwright BioConnect 2022 Conference
ANN ARBOR, MI / ACCESSWIRE / December 15, 2021 / Zomedica Corp. (NYSE American:ZOM), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals,... 
From Zomedica Corp.
Via AccessWire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.